Cures Within Reach For Cancer


Cures Within Reach for Cancer, a Boston-based initiative sponsored by Cures Within Reach, is developing new cancer treatments using inexpensive drugs that are already FDA-approved for other indications and have a long history of safe patient use. The team is initially focusing on the around 100 non-cancer generic drugs that have shown efficacy for cancer in early clinical studies. The development of these promising treatments is stalled due to a lack of commercial interest. Cures Within Reach for Cancer aims to fill this gap in our drug development system to ensure that these drugs, which could transform the treatment of many types of cancer, undergo the clinical testing necessary to fully evaluate them for their cancer use. Our main objectives are to identify the therapies with the strongest evidence of effectiveness for cancer, facilitate definitive clinical trials, and create sustainable funding models. We are building the Oncology Repurposing Engine™ for systematic evidence synthesis and analysis, prioritization of repurposing opportunities, and scoping of clinical trials. This information hub will be freely available to researchers, clinicians, patients, and healthcare payers to democratize insights.





For more information, please contact Laura Kleiman at and connect with us on Facebook and Twitter!




Click here to sign up for our eNewsletter today!

Please include your Full Name* and Email Address*


If the link above doesn't work, please email with your Full Name and Email Address to sign up!


Cures Within Reach

134 N. LaSalle, #1130
Chicago, IL 60602

All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes. 

Partnership for Cures DBA Cures Within Reach is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.


Friday the 22nd. Copyright 2018 Cures Within Reach.